Hamel Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-4,280
| Closed | -$205K | – | 82 |
|
|
2016
Q4 | $205K | Hold |
4,280
| – | – | 0.11% | 82 |
|
|
2016
Q3 | $231K | Hold |
4,280
| – | – | 0.12% | 79 |
|
|
2016
Q2 | $232K | Hold |
4,280
| – | – | 0.12% | 83 |
|
|
2016
Q1 | $216K | Sell |
4,280
-5,100
| -54% | -$257K | 0.11% | 87 |
|
|
2015
Q4 | $473K | Sell |
9,380
-5,380
| -36% | -$271K | 0.3% | 62 |
|
|
2015
Q3 | $709K | Sell |
14,760
-15,300
| -51% | -$735K | 0.5% | 55 |
|
|
2015
Q2 | $1.57M | Sell |
30,060
-11,840
| -28% | -$616K | 1.03% | 37 |
|
|
2015
Q1 | $2.42M | Buy |
41,900
+860
| +2% | +$49.6K | 1.6% | 20 |
|
|
2014
Q4 | $2.19M | Buy |
41,040
+18,160
| +79% | +$970K | 1.42% | 24 |
|
|
2014
Q3 | $1.31M | Buy |
22,880
+12,308
| +116% | +$707K | 0.88% | 42 |
|
|
2014
Q2 | $707K | Sell |
10,572
-220
| -2% | -$14.7K | 0.47% | 64 |
|
|
2014
Q1 | $720K | Sell |
10,792
-608
| -5% | -$40.6K | 0.5% | 61 |
|
|
2013
Q4 | $760K | Buy |
+11,400
| New | +$760K | 0.53% | 60 |
|